Zevra Therapeutics
ZVRA
#7323
Rank
A$0.78 B
Marketcap
A$13.23
Share price
-3.42%
Change (1 day)
-11.82%
Change (1 year)

Earnings for Zevra Therapeutics (ZVRA)

Earnings in 2026 (TTM): A$0.13 Billion

According to Zevra Therapeutics's latest financial reports the company's current earnings are A$0.14 Billion. In 2025 the company made an earning of A$0.14 Billion, an increase over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zevra Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.13 B-4.95%
2025 A$0.14 B-214.33%
2024 -A$0.13 Billion107.97%
2023 -A$60.15 Million-5.55%
2022 -A$63.68 Million418.02%
2021 -A$12.3 Million44.87%
2020 -A$8.49 Million-68.85%
2019 -A$27.24 Million-63.58%
2018 -A$74.8 Million37.16%
2017 -A$54.53 Million283.79%
2016 -A$14.21 Million-81.21%
2015 -A$75.63 Million130.03%
2014 -A$32.88 Million